Biocon Biologics India Limited — Bevacizumab Exporter Profile
Indian Pharmaceutical Exporter · #2 for Bevacizumab · $2.3M export value · DGFT Verified
Biocon Biologics India Limited is the #2 Indian exporter of Bevacizumab with $2.3M in export value and 46 verified shipments. Biocon Biologics India Limited holds a 4.9% market share in Bevacizumab exports across 12 countries. The company exports 5 pharmaceutical products worth $7.8M across 4 therapeutic categories.
Biocon Biologics India Limited — Bevacizumab Export Profile: Buyers & Destinations
Where Does Biocon Biologics India Limited Export Bevacizumab?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NETHERLANDS | $945.2K | 19 | 57.8% |
| BRAZIL | $200.0K | 4 | 12.2% |
| SOUTH AFRICA | $159.8K | 4 | 9.8% |
| SRI LANKA | $121.0K | 12 | 7.4% |
| EGYPT | $50.0K | 7 | 3.1% |
| AUSTRALIA | $50.0K | 1 | 3.1% |
| COLOMBIA | $50.0K | 1 | 3.1% |
| LIBYA | $50.0K | 1 | 3.1% |
| ZIMBABWE | $7.2K | 1 | 0.4% |
| PARAGUAY | $1.4K | 1 | 0.1% |
Biocon Biologics India Limited exports Bevacizumab to 14 countries. The largest destination is NETHERLANDS accounting for 57.8% of Biocon Biologics India Limited's Bevacizumab shipments, followed by BRAZIL (12.2%) and SOUTH AFRICA (9.8%). These destinations reflect Biocon Biologics India Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Bevacizumab from Biocon Biologics India Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| BIOCON BIOLOGICS UK LIMITED | NETHERLANDS | $855.0K | 18 |
| XXOCOXXBIOXXGICXXUK XXMITXX | AUSTRALIA | $450.0K | 9 |
| XXOSIXXLARXXOLLXXORAXXONSXXRELXXD LXXITEX | NETHERLANDS | $100.0K | 2 |
| XXOSIXXLARXXNEWXX LIXXTED | COLOMBIA | $57.2K | 2 |
| MEDMART PHARMA (PVT) LTD | SRI LANKA | $55.5K | 4 |
| XXOSWXXS PXXRMAXXUTIXXL SX | LIBYA | $50.0K | 1 |
| MEDMART PHARMA PVT LTD | SRI LANKA | $38.3K | 3 |
| MEDMART PHARMA PRIVATE LIMITED | SRI LANKA | $16.8K | 3 |
| MEDMART PHARMA (PRIVATE) LIMITED | SRI LANKA | $10.4K | 2 |
| QUIMFA S A | PARAGUAY | $1.4K | 1 |
Biocon Biologics India Limited supplies Bevacizumab to 16 buyers globally. The largest buyer is BIOCON BIOLOGICS UK LIMITED (NETHERLANDS), followed by XXOCOXXBIOXXGICXXUK XXMITXX (AUSTRALIA) and XXOSIXXLARXXOLLXXORAXXONSXXRELXXD LXXITEX (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Bevacizumab Export Value and How Much Does Biocon Biologics India Limited Contribute?
India exported $15.2M worth of Bevacizumab through 1,408 shipments from 196 suppliers to 100 countries, serving 346 buyers globally. Biocon Biologics India Limited contributes $2.3M to this total, accounting for 4.9% of India's Bevacizumab exports. Biocon Biologics India Limited ships Bevacizumab to 14 countries through 16 buyers.
What Is the Average Shipment Value for Biocon Biologics India Limited's Bevacizumab Exports?
Biocon Biologics India Limited's average Bevacizumab shipment value is $50.0K per consignment, based on 46 shipments totaling $2.3M. The largest destination is NETHERLANDS (57.8% of Biocon Biologics India Limited's Bevacizumab exports).
How Does Biocon Biologics India Limited Compare to Other Indian Bevacizumab Exporters?
Biocon Biologics India Limited ranks #2 among 196 Indian Bevacizumab exporters with a 4.9% market share. The top 3 exporters are DR.REDDY'S LABORATORIES LTD ($6.5M), BIOCON BIOLOGICS INDIA LIMITED ($2.3M), RELIANCE LIFE SCIENCES PRIVATE LIMITED ($2.1M). Biocon Biologics India Limited processed 46 shipments to 12 destination countries.
What Bevacizumab Formulations Does Biocon Biologics India Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ABEVMY 25 MG/ML BEVACIZUMAB | $666.1K | 14 |
| ABEVMY 25 MG/ML (BEVACIZUMAB | $400.0K | 8 |
| ABEVMY 25 MG/ML BEVACIZUMAB | $100.0K | 2 |
| ABEVMY BEVACIZUMAB | $51.4K | 3 |
| BEVACIZUMAB INJECTION | $50.0K | 3 |
| ABEVMY 25 MG/ML (BEVACIZUMAB INJECTION | $50.0K | 1 |
| BEVAMYL 25 MG/ML BEVACIZUMAB | $50.0K | 1 |
| ABEVMY 25 MG/M BEVACIZUMAB | $50.0K | 1 |
| ABEVMY 25 MG/M (BEVACIZUMAB | $50.0K | 1 |
| BEVAMYL 25 MG/ML BEVACIZUMAB | $38.9K | 1 |
Biocon Biologics India Limited exports 28 distinct Bevacizumab formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ABEVMY 25 MG/ML BEVACIZUMAB with 14 shipments worth $666.1K.
Regulatory Requirements: Exporting Bevacizumab to Key Markets
What Biocon Biologics India Limited must comply with to export Bevacizumab to its top destination countries
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Biocon Biologics India Limited Compare to Nearest Bevacizumab Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LTD | $6.5M | 131 | 15 | $50.0K |
| 2 | BIOCON BIOLOGICS INDIA LIMITED ★ | $2.3M | 46 | 12 | $50.0K |
| 4 | RELIANCE LIFE SCIENCES PRIVATE LIMITED | $2.1M | 73 | 12 | $29.1K |
| 5 | ZYDUS LIFESCIENCES LIMITED | $1.1M | 21 | 4 | $50.0K |
Biocon Biologics India Limited ranks #2 among 196 Indian Bevacizumab exporters. Average shipment value of $50.0K compared to the market average of $77.5K. The closest competitors by value are DR.REDDY'S LABORATORIES LTD and RELIANCE LIFE SCIENCES PRIVATE LIMITED.
Which Indian Ports Ship Bevacizumab Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 345 | 24.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 327 | 23.2% |
| HYDERABAD ACC (INHYD4) | 132 | 9.4% |
| Bombay Air | 89 | 6.3% |
| DELHI AIR CARGO ACC (INDEL4) | 48 | 3.4% |
| DELHI AIR | 47 | 3.3% |
| HYDERABAD AIR | 36 | 2.6% |
| AHEMDABAD AIR | 32 | 2.3% |
What Other Advanced Oncology Products Does Biocon Biologics India Limited Export?
Biocon Biologics India Limited also exports these advanced oncology products. Each links to the detailed product page.
About Biocon Biologics India Limited
Biocon Biologics India Limited exports 5 products worth $7.8M. Beyond Bevacizumab, top products include Ras, Trastuzumab, Insulin, Ustekinumab. View the complete Biocon Biologics India Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bevacizumab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Bevacizumab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Biocon Biologics India Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 56 individual customs records matching Biocon Biologics India Limited exporting Bevacizumab, covering 28 formulations to 14 countries via 16 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 100+ countries, 346+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Bevacizumab Export Data from Biocon Biologics India Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Biocon Biologics India Limited's Bevacizumab exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Biocon Biologics India Limited
Full Company Profile →
5 products · $7.8M total trade · 4 categories
Bevacizumab Stats
Company Overview
Top Products by Biocon Biologics India Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Biocon Biologics India Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bevacizumab. For current shipment-level data, contact TransData Nexus.